Why big pharma is teaming up with AI giants to speed up drug discovery and make work easier for health care workers | Fortune
Summary
Big pharma is deepening partnerships with AI companies to accelerate drug discovery and improve healthcare operations. Eli Lilly is building an Nvidia-powered supercomputer and AI factory, while Johnson & Johnson is using Nvidia models to simulate surgical environments and train doctors. The article argues that life sciences companies want customized AI tools that reflect their own data and workflows, not generic platforms. It also notes that AI vendors are tailoring offerings for the sector as budgets grow and use cases become more specialized.
Classifications
industries
Fintech & Banking
applications
Anti Piracy
AskAI Classifications
Labels
Financial Software
SaaS
Data & Analytics
